A Phase I Dose Finding Study of RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer.
Phase of Trial: Phase I
Latest Information Update: 12 Jul 2015
At a glance
- Drugs Everolimus (Primary) ; Capecitabine; Oxaliplatin
- Indications Gastric cancer
- Focus Adverse reactions; Biomarker
- 03 Jul 2013 Planned end date changed from 1 Nov 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 09 Apr 2012 Planned number of patients changed from 20 to 40 as reported by ClinicalTrials.gov.
- 09 Apr 2012 Planned end date changed from 1 Feb 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov.